Citation:Vickers AJ, Ulmert D, Sjoberg DD, Bennette CJ, Bjork T, Gerdtsson A et al 2013

Citation

Vickers AJ, Ulmert D, Sjoberg DD, Bennette CJ, Bjork T, Gerdtsson A et al. Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study. BMJ 2013;346: f2023.

This is a publication of Malmoe Preventive Project

Critical appraisals

• Assign a critical appraisal

Critical appraisal link	Clinical question	Assigned to	Status
Vickers AJ, Ulmert D, Sjoberg DD, Bennette CJ, Bjork T, Gerdtsson A et al 2013	For asymptomatic men without a prostate cancer diagnosis, what is the recommended PSA testing strategy with respect to age at first PSA test, subsequent testing intervals and cut-off levels?	Dr. med. univ. Dana Stefanovic	completed
Vickers AJ, Ulmert D, Sjoberg DD, Bennette CJ, Bjork T, Gerdtsson A et al 2013 2	For asymptomatic men without a prostate cancer diagnosis, what is the recommended PSA testing strategy with respect to age at first PSA test, subsequent testing intervals and cut-off levels?	Cindy Peng	completed
Vickers AJ, Ulmert D, Sjoberg DD, Bennette CJ, Bjork T, Gerdtsson A et al 2013 3	For asymptomatic men without a prostate cancer diagnosis, what is the recommended PSA testing strategy with respect to age at first PSA test, subsequent testing intervals and cut-off levels?	Cindy Peng	completed
Vickers AJ, Ulmert D, Sjoberg DD, Bennette CJ, Bjork T, Gerdtsson A et al 2013 4	For asymptomatic men without a prostate cancer diagnosis, what is the recommended PSA testing strategy with respect to age at first PSA test, subsequent testing intervals and cut-off levels?	Tracy Tsang	completed

Compare quality appraisals for each clinical question

• [[Clinical question:For asymptomatic men without a prostate cancer diagnosis, what is the recommended PSA testing strategy with respect to age at first PSA test, subsequent testing intervals and cut-off levels?|]] (compare critical appraisals)
• [[Clinical question:For asymptomatic men without a prostate cancer diagnosis, what is the recommended PSA testing strategy with respect to age at first PSA test, subsequent testing intervals and cut-off levels?|]] (compare critical appraisals)
• [[Clinical question:For asymptomatic men without a prostate cancer diagnosis, what is the recommended PSA testing strategy with respect to age at first PSA test, subsequent testing intervals and cut-off levels?|]] (compare critical appraisals)

Cited by

1. Malmoe Preventive Project
2. PSA Testing strategies
3. Table 2.4. Estimates of increments in absolute percentage cumulative risk of prostate cancer death above the risk at a baseline PSA of < 1 ng/mL (Orsted et al, 2012) or the lowest quarter of the PSA distribution (Vickers et al 2013) by age, length of follow-up and baseline PSA level
4. Table 2.4. Estimates of increments in absolute percentage cumulative risk of prostate cancer death above the risk at a baseline PSA of < 1 ng/mL (Orsted et al, 2012) or the lowest quarter of the PSA distribution (Vickers et al 2013) by age, length of follow-up and baseline PSA level